Oregon State University is joining universities and academic health centers nationally in making licensing agreements for its intellectual property quickly executable to speed up the development of technologies that can be used to diagnose, treat and prevent COVID-19.
*IP that is included in currently sponsored research agreements or that is otherwise incumbered, some therapeutic agents, and IP that is co-owned may not be available. Verify IP availability by contacting Joe.Christison@oregonstate.edu.
Once IP has been identified as available, and the Licensee requirements have been submitted, we will briefly review and those that meet the criteria without question will be provided an executable license via DocuSign. If there are questions that need to be clarified prior to a license, we will send via email.